After a dismissal week of falling share prices, the FTSE 100 managed to regain its confidence and he...
After a dismissal week of falling share prices, the FTSE 100 managed to regain its confidence and head back into the 'blue'. The FTSE 100 index closed up 0.5% to 4024.8p, having earlier in the day fallen yet again by another 0.7%. Key ingredient was AstraZeneca. The huge pharmaceutical empire drove the FTSE 100 trading back over the 4,000 points mark after the US Food and Drug Administration said it would support approval for the sale of its cholesterol drug. AstraZeneca gained 95p or 4% to £25.00 exact by close of business. The parent group behind IFA portal the Exchange - M...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes